---
layout: single
title: "New update on dry Macular Degeneration treatment: SYFOVRE® (pegcetacoplan injection) from Apellis Pharmaceuticals"
---

On August 22, 2023, Apellis Pharmaceuticals provided an update on their SYFOVRE® (pegcetacoplan injection) treatment for Dry Macular Degeneration. 

Check out thier press release for more information [here](https://investors.apellis.com/news-releases/news-release-details/apellis-provides-updates-injection-kits-and-rare-safety-events).